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Abstract.  We have investigated the role of topoisom- 
erase II (topo II) in mitotic chromosome assembly and 
organization in vitro using Xenopus egg extracts. When 
sperm chromatin was incubated with mitotic extracts, 
the highly compact chromatin rapidly swelled and con- 
comitantly underwent local condensation.  Further 
incubation induced the formation of entangled thin 
chromatin fibers that eventually resolved into highly 
condensed individual chromosomes.  This in vitro 
system made it possible to manipulate mitotic chromo- 
somes in their assembly condition without any isola- 
tion or stabilization steps.  Two complementary ap- 
proaches,  immunodepletion and antibody blocking, 
demonstrated that topo II activity is required for chro- 
mosome assembly and condensation.  Once condensa- 
tion was completed, however, blocking of topo II ac- 
tivity had little effect on the chromosome morphology. 
Immunofluorescent studies showed that topo II was 
uniformly distributed throughout the condensed chro- 
mosomes and was not restricted to the chromosomal 
axis.  Surprisingly,  all detectable topo II molecules 
were easily extracted from the chromosomes under 
mild conditions where the shape of chromosomes was 
well preserved.  Our results show that topo II is essen- 
tial for mitotic chromosome assembly, but does not 
play a  scaffolding role in the structural maintenance  of 
chromosomes assembled in vitro.  We also present evi- 
dence that changes of DNA topology affect the distri- 
bution of topo II in mitotic chromosomes in our 
system. 
T  H~ structural  organization  of chromatin  changes dra- 
matically in the cell cycle.  At the onset of mitosis, 
dispersed chromatin in the interphase  nucleus is in- 
duced to condense, eventually  producing mitotic chromo- 
somes. Highly organized packing of chromatin into the con- 
densed chromosomes and their proper interaction  with the 
mitotic spindle are essential  to ensure the fidelity of subse- 
quent chromosome segregation.  Although  recent technical 
advances have made it possible to visualize spatial and tem- 
poral coordination  of the dynamic chromatin  behavior by 
real-time analysis  in vivo (Hiraoka et al.,  1989),  little  is 
known about the molecular mechanisms underlying dynamic 
changes of large scale chromosome structure during the pro- 
gression of the cell cycle. 
Amphibian egg extracts provide an ideal system to inves- 
tigate  chromosome assembly and its structural  changes  in 
vitro,  Using a Rana pipiens egg extract,  Lohka and Masui 
(1983)  originally  developed an  in  vitro  system  in  which 
sperm chromatin  was induced to form interphase  nuclei and 
then  converted  into  condensed  chromosomes.  More  re- 
cently, it has been demonstrated that,  in cell cycle-specific 
Xenopus egg extracts,  naked DNA is capable of acting as a 
template for assembly of both interphase  nuclei (Newmeyer 
et al.,  1986; Blow and Laskey,  1986; Newport, 1987) and 
mitotic chromosomes (Hirano and Mitchison,  1991). 
Topoisomerase II (topo H) t is an enzyme that  regulates 
the topological structures of DNA by transient breakage and 
rejoining of double-stranded DNA. Genetic studies in yeasts 
have shown that topo II is required for condensation as well 
as  segregation  of mitotic  chromosomes  (Uemura  et  al., 
1987). Involvement of topo II in condensation  has also been 
suggested  by in vitro experiments  using Xenopus egg ex- 
tracts:  addition  of a topo II inhibitor VM-26 blocked con- 
densation of  both rat liver nuclei (Newport and Spann,  1987) 
and chromosome-like structures  assembled around naked 
DNA  (Hirano  and  Mitchison,  1991). One  problem with 
these inhibitor experiments is that it is not clear if the inhibi- 
tion of condensation  was due to a specific inhibition of topo 
II activity or a nonspecific effect of protein-linked  DNA gaps 
induced by the drug treatment  (Chen et al., 1984). Recently 
the requirement for topo II in chromosome condensation has 
been demonstrated  in  vitro  by specific  immunodepletion 
using  somatic  cell  and  Xenopus egg  extracts  (Wood  and 
Earnshaw,  1990; Adachi et al., 1991). These studies used in- 
terphase nuclei with variable levels of endogenous topo II as 
substrates  and  showed  that  chromosome condensation  is 
closely correlated with the level of topo 1I present in the reac- 
1. Abbreviations used in thispaper: EtBr, ethidium bromide; topo II, topo- 
isomerase II. 
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duce HeLa nuclei to condense, but failed to produce mitotic 
chromosomes from chicken erythrocyte nuclei which have 
a low level of endogenous topo I/. 
In addition to its catalytic activity,  topo II may also play 
a structural role in the maintenance of mitotic chromosomes 
since it has been identified as a major component of the chro- 
mosome  scaffold  (Earnshaw  et  al.,  1985;  Gasser  et  al., 
1986).  The chromosome scaffold was originally character- 
ized as a residual framework of metaphase chromosomes af- 
ter histone extraction (Paulson and Laemmli,  1977) and is 
thought to anchor the chromatin loop domains (reviewed by 
Gasser et al., 1989). DNA sequences that preferentially bind 
to the chromosome scaffold (called scaffold-associated re- 
gion [SAR]) was found to contain a cluster of topo II cleav- 
age consensus.  Taken together,  it has been proposed that 
topo II plays  a  scaffolding role in the organization of the 
chromatin loops via a direct interaction with SAR (Gasser 
and Laemmli,  1987). 
The existence of the  scaffold structure  in intact mitotic 
chromosomes  has,  however,  remained  controversial.  The 
original harsh conditions for scaffold preparation  have been 
suspected to potentially induce formation of an artifactual 
aggregation of proteins (Okada  and Comings,  1980;  Had- 
laczky et al.,  1981;  Paulson,  1989).  Recent analyses using 
mAbs raised against  the chromosome scaffold fraction re- 
vealed that the fraction consists not only of chromosomal 
proteins, but also of other proteins that normally bind to the 
mitotic spindle (reviewed by Earnshaw,  1991;  Compton et 
al., 1991,  1992). Substantial  changes of antigen distribution 
may be induced in drug-arrested  mitotic cells in vivo before 
chromosome  isolation.  Thus,  alternative  experimental 
procedures will be required for dissecting mitotic chromo- 
somes in a condition where they are actually assembled. 
In this report, we used sperm chromatin, which was found 
to lack detectable amounts of endogenous topo II, to inves- 
tigate the specific role of topo II in mitotic chromosome as- 
sembly and organization in vitro. Using Xenopus egg extracts 
in which the level of active topo II molecules can be im- 
munochemicaUy manipulated, we present evidence that topo 
II is required for mitotic chromosome assembly and conden- 
sation, but does not play a scaffolding role in the structural 
maintenance of chromosomes assembled in this system. We 
also show that this in vitro system is useful for manipulating 
mitotic chromosomes in their assembly  condition without 
any isolation or stabilization steps. 
Materials and Methods 
Preparation of Mitotic Extracts 
Mitotic extracts  were prepared from eggs of Xenopus lae~'s as described 
previously  (Newport and Spann,  1987; Murray et al.,  1989;  Hirano and 
Mitchlson, 1991) with minor modifications.  In brief, mitotic crude extracts 
were prepared by crushing unfertilized eggs in EB (80 mM ~-glycerophos- 
phate, pH 7.3, 15 mM MgC12, 20 mM EGTA and 1 mM DTF,  with 10 
~g/ml leupeptin, chymostatin, and pepstatin). The crude extracts were fur- 
ther fractionated by ultracentrifugation at 50,000 rpm for 2 h at 4~  (TLS- 
55 rotor; Beckman Instruments, Inc., Palo Alto, CA). The soluble fractions 
were carefully removed using a 20-gange needle, and recentrifuged at 50,000 
rpm for 30 rain to remove residual membranes. 50-~d aliquots were frozen 
in liquid nitrogen and stored at -80~  (high-speed supernatants). We found 
that in some batches of extracts slight dilution of extracts (up to 2-fold) pro- 
duced better results than those obtained from undiluted extracts.  Twofold 
dilution of extracts did not affect the efficiency of nucleosome assembly on 
a closed circular plasmid DNA as judged by a supercoiling  assay. 
Preparation of Sperm Chromatin 
Demembranated Xenopus sperm chromatin was prepared by the method de- 
scribed by Gurdon (1976), and stored in 30% glycerol at -80~ 
Cloning of cDNAs Encoding Xenopus Topo H 
To prepare specific antisera against the Xenopus topo II protein, we isolated 
cDNAs encoding Xenopus topo II and bacterially expressed fusion proteins 
to be used as antigens. We selected two amino acid stretches of topo 11 that 
are completely  conserved among four eukaryotic  species  (Giaever et ai., 
1986; Uemura et al.,  1986; Tsai-Pflugfelder  et al.,  1988; Wyckoff et al., 
1989) and designed a  set of polymerase chain reaction (PCR) primers. 
Primer 1 encodes the amino acid sequence LAQNFVG (amino acid 770-776 
in human topo II) on the coding strand, and primer 2 encodes the sequence 
NGAEGIG (amino acid 850-856) on the noncoding strand. The nucleotide 
sequence of primer 1 is 5'GATGGATCC(TC)T(ATCJC)GC(ATCJC)CA(AG) 
AA(TC)TT(TC)GT(ATGC)GG3'  (1,024-fold degenerate).  The sequence for 
primer 2 is 5' GACCTGCAGCC(ATG)AT(ATGC)CC(TC)TC(ATGC) 
GC(ATC~)CC(AG)TT3' (768-fold degenerate).  All nucleotides  in paren- 
theses were included at that position. 
Poly(A) + RNA was isolated from Xenopus eggs using FastTrack mRNA 
isolation kit (Invitrogen,  San Diego,  CA) according to manufacturer's in- 
struction, cDNA produced from the RNA with oligo(dT) priming was used 
as a template for PCRs. A reaction amplified a single band with an expected 
length of 270 bp. A Xenopus embryo kgtl0 cDNA library (kindly provided 
by E. Amaya and M. W. Kirschner, University of California, San Francisco, 
CA) was screened using this PCR fragment as a probe and two classes of 
cDNA were obtained. The first class of cDNA (designated XT-1) was •6.5 
kb long and contained the entire length of topo II coding region. The second 
class (designated XT-2) was ,~3 kb long and was missing the NH2-terminal 
half  of coding region. Alignment  of these two sequences and those of human 
topo II isotypes  (Chang et al.,  1989) revealed that XT-1 and XT-2 appear 
to encode the ce (170-kD form) and/3 (180-kD form) type of topo II, respec- 
tively. We also found that XT-1 (topo II c0 was highly expressed in prolifer- 
ating cells such as eggs and embryos, whereas XT-2 (topo II/~) was predom- 
inantly expressed in nonproliferating Go cells such as liver. This is in good 
agreement  with  the  differential  expression pattern of topo  II  isotypes 
reported in mammalian cells (Woessner et al., 1991) and supports the con- 
clusion described above. 
Preparation of  Anti-topo H Antisera 
A fusion protein containing a COOH-terminal domain of topo II a  was ex- 
pressed in E. coil using T7 RNA polymerase-dependent expression system 
(Smdier et al.,  1990).  A 3.8*kb Hind~I fragment of the Xenopus topo II 
cDNA was  subcloned into a  cloning vector pGEM7Zf(+) (Promega 
Corp.,  Madison, WI). The resulting plasmid pXT115 was digested  with 
BglII and BamI-II, and a 3.0-kb BglII-BamHI fragment was ligated into an 
expression vector pETllc (Smdier et ai., 1990) to generate pXT135, which 
can express an in-frame fusion ofT'/gene 10 product (11 amino acids) and 
a COOH-terminal domain (,,0800 amino acids) of topo II c~. The plasmid 
was introduced into an E. coli strain BL21(DE3),  which contained the T7 
RNA polymerase gene under the control of/ac UV5 promoter.  Expression 
of the fusion protein was induced for 3 h by the addition of 1 mM isopropyl- 
~-thiogaiactopyranoside  (IPTG) and inclusion bodies were isolated as de- 
scribed by Sambrook et al. (1989). The insoluble materials were resolved 
in preparative SDS-polyacrylamide  gels,  and after brief staining with 
Coomassie blue, fusion protein bands were cut out. The polypeptides  were 
electroeluted in 20 ram sodium phosphate, pH 7.5, containing 0.1% SDS, 
dialyzed against TBS (20 mM Tris-HC1, pH 7.5, 150 mM NaC1), and used 
as antigens. Immunizations and bleeds were carried out by the Berkeley An- 
tibody Company (Richmond, CA). Two antisera from different rabbits rec- 
ognized a common polypeptide of 180 kD, which corresponds well to the 
reported size of Xenopus egg topo II (Luke and Bogenhagen,  1989). One 
of them recognizing a single band of 180 kD on blots was used for depletion 
experiments.  Affinity purification of anti-topo II antibodies was performed 
as  follows.  The gel-purified  fusion protein was  dialyzed  against 0.1  M 
MOPS, pH 7.5, and was coupled to Affigel 10 agarose (Bio-Rad Laborato- 
ries, Richmond, CA) according to the manufacturer's instructions. An anti- 
topo II antiserum was passed over the fusion protein column three times, 
and the column was washed initially with TBS and then with 20 mM Tris- 
HC1, pH 7.5/0.5 M NaC1. Anti-topo II IgG was eluted with 0.2 M glycine- 
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stored at 4"C. The affinity-purified anti-topo II IgG was found to inhibit 
decatenation activity of topo II in vitro. 
Immunodepletion of Topo H 
Protein A-Sepharose CL-4B (Sigma Chemical Co., St.  Louis, MO) was 
washed five times with TBS, mixed with an equal volume of either rabbit 
antiserum raised against the COOH-terminal domain of the Xenopus topo 
II c~ or preimmune serum collected from the same rabbit, and incubated at 
4~  for 1-2 h. The Sepharose was washed three times with TBS and twice 
with EB. After the final wash, residual buffer was removed as completely 
as possible using a 23-gauge needle. Undiluted extract was added to an 
equal volume of the antibody-loaded Protein A-Sepharose and incubated on 
ice for 1 h with occasional agitation. The treated extract was then separated 
from the Sepharose by centrifugation, and used as the depleted extract. To 
confirm the specificity  of  depletion, topo H-depleted extracts were also pre- 
pared using affinity-purified anti-topo II IgG (see above) and used in some 
experiments. 
Assays for Topo H Activity and Nucleosome Assembly 
Topo II activity was assayed for the ability to decatenate kinetoplast DNA 
(Marini et ai., 1980).  Kinetoplast DNA (TopoGEN, Inc., Columbus, OH) 
was added to twofold diluted extracts at a final concentration of 10 #g/rni 
and incubated at 23"C. At appropriate intervals, the reactions were termi- 
nated by adding 20 vol of stop solution (20 mM Tris-HCl, pH 8.0, 20 mM 
EDTA, 0.5% SDS, and 500 #g/ml Proteinase K). After incubation at 55~ 
for 60 rain, the reaction mixture was deproteinized with phenol and the 
DNA was precipitated with ethanol. After centrifugation the pellet DNA 
was dissolved in 12 #i of TE (10 mM Tris-HCl, pH 8.0, and 1 mM EDTA), 
and electrophoresed on a 0.8% agarose gel. Nucleosome assembly was ex- 
amined by a supercoiling assay as described previously (Hirano and Mitchi- 
son, 1991). 
Assays for Mitotic Chromosome Assembly 
and Condensation 
Standard reactions for mitotic chromosome assembly contained 20 #1 of mi- 
totic extract (high-speed supernatant), 1 #1 of sperm chromatin (final con- 
centratiun of 2  x  10  ~ nuclei/ml), and an ATP-reganerating system (final 
concentration of 1 mM ATP, 10 mM creatine phosphate, and 50 #g/ml crea- 
tine kinase). Reactions wee incubated at room temperature (230C)  for up 
to 3 h. To monitor structural changes of sperm chromatin, aliquots were 
removed at different time points, mixed with an equal vol of fixative (50% 
[wt/vol]  glycerol,  3.7%  formaldehyde, and  1 #g/ml,  I-Ioechst  33258  in 
MMR),  and observed by fluorescent microscopy (Photoscope HI;  Carl 
Zeiss, Inc., Thornwood, NY). MMR consisted of 100 mM NaCI, 2 mM 
KC1,  1 mM MgSO4,  2  mM CaC12, 0.1  mM EGTA,  and 5  mM Hepes, 
pH 7.8. 
Topo H Readdition and Antibody Blocking 
Highly purified Drosophila  topo H  was a  generous gift of J.  Swedlow 
(University of California, San Francisco, CA). This enzyme was purified 
from Drosophila embryos by the method of Sheltun et al. (1983).  On SDS- 
PAGE, it consists of a predominant band of 170 kD and two minor bands 
(135 and 155 kD) that are most likely to represent degradation products of 
the major band. Based on Luke and Bogenhagen (1989) and our quantitative 
immunoblot analyses, we estimate that topo II concentration in our high- 
speed supernatants is ,,02 #g/ml. We found that the addition of Drosophila 
topo II at the physiological concentration was sufficient  to restore condensa- 
tion activity in topo H-depleted extracts (at a final concentration of 1 #g/ml 
topo II in twofold diluted extracts; see Fig. 3). For antibody blocking experi- 
ments,  1/10 vol of TBS  containing different concentrations of affinity- 
purified anti-topo II IgG were added. As negative controls, the same con- 
centrations of normal rabbit IgG (Sigma Chemical Co.) were used. VM-26 
(4'-demethylepipodophyllotoxin  thenylidane-/5-v-gluceside;  a generous gift 
of Bristol-Meyers, Syracuse, NY) was dissolved in DMSO as a stock solu- 
tion of 10 mM and diluted with EB immediately before use. We found that 
the final DMSO concentration of up to 1.0% did not affect mitotic chromo- 
some assembly and condensation. 
Immunofluorescence and Immunoblotting 
Immunofluorescent  staining  was  performed  as  described  previously 
(Hirano and Mitchison, 1991).  For topo II staining, afffinity-purified anti- 
topo II IgG was used at a concentration of 1 ~g/ml. MPM-2 (generously 
provided by P. N. Rao, The University of Texas,  M.D. Anderson Cancer 
Center, Houston, TX; Davis et al., 1983) was used at a dilution of 1:500. 
Immunoblotting was performed as described by Harlow and Lane (1988) 
using ECL (enhanced chemiluminescence) detection system (Amersham 
Corp., Arlington Heights, IL). 
Extraction of Mitotic Chromosomes in 
Assembly Mixtures 
Mitotic chromosomes were assembled in the standard assembly mixtures 
(prepared in EB) for 2 h and then mixed with an equal vol of EB containing 
increasing concentrations of NaCI. The treatment buffer contained EB plus 
2 ￿  concentrated NaCl so that buffer composition of the final mixture was 
adjusted to EB plus lx NaCI. After a 10-rain incubation at room tempera- 
ture, the chromosomes were fixed and processed for immunofluorescence. 
Alternatively, assembly mixtures were layered on EB containing 30% su- 
crose and spun at 12,000 rpm for 15 rain. After washing interface five times 
with  EB,  chromosomes  recovered in  the  pellet  were  suspended  in  a 
SDS-sample buffer and analyzed by immnnoblotting. Dextran sulfate ex- 
tractiun was performed in the same way. In some experiments, chromo- 
somes were pretreated with metal ions before extraction. 
Results 
Structural Rearrangements of Sperm Chromatin in 
Mitotic Extracts 
Lohka and Masui (1984) originally found that an amphibian 
egg extract prepared in the presence of EGTA was able to 
directly convert sperm chromatin into a condensed state. We 
have  investigated  in  detail  intermediate  stages  of mitotic 
chromosome assembly and condensation using Xenopus egg 
mitotic extracts. Demembranated sperm chromatin exhibits 
a highly compact, snake-like shape (Fig.  1 a). Upon incuba- 
tion with mitotic extracts,  this compact chromatin rapidly 
swelled,  increasing more than threefold in both length and 
width,  and  concomitantly  underwent  local  condensation 
(Fig.  1 b). After 60 min, thin chromatin fibers (0.2-0.4 #m 
in  diameter) became clearly visible in a  chromatin mass 
(Fig. 1 c). The fibers were entangled with each other, making 
it difficult to trace the entire length of a  single individual 
fiber.  After  90-120  min,  condensation  proceeded  and 
thicker, rod-shaped chromosome structures (~0.8 #m in di- 
ameter) were obsered (Fig.  1 d).  At this  time point,  in- 
dividual chromosomes were clearly resolved, which were 
clustered in a mass (Fig.  1 d) or dispersed into the extract 
(Fig.  1 e). The number of chromosomes observed in each 
mass corresponded roughly to that of the haploid genome of 
Xenopus/aev/s (n =  18; Tymowska and Kobel, 1972). Not 
surprisingly, we did not find sister chromatids in the chromo- 
some because sperm chromatin was directly induced to con- 
dense in the absence of DNA replication in this assay. The 
condensation state of the final products was similar to that 
of mitotic chromosomes that were induced to condense after 
DNA replication was completed in interphase nuclei (data 
not shown, see also Sawin and Mitchison, 1991). The struc- 
tural changes of sperm chromatin proceeded in a highly syn- 
chronous manner: at most time points all chromatin struc- 
tures were in a similar condensation state. We classified the 
discrete stages in chromatin rearrangement as follows: (a) 
swelling of highly compact sperm chromatin; (b) local con- 
densation;  (c) formation of entangled thin fibers;  and (d) 
resolution of highly condensed chromosomes. Although the 
first two stages simultaneously occur in mitotic extracts, we 
were  able to distinguish them experimentally  in terms  of 
topo II requirements as shown below. 
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extracts. Demembranated sperm chromatin exhibits a highly com- 
pact snake-like shape (a). The chromatin was incubated with a mi- 
totic extract at 230C. After 30-rain (b),  1-h (c), and 2-h (d and e) 
incubations,  condensation  intermediates  were fixed and  stained 
with  Hoechst  33258. Individual  chromosomes  were often found 
dissociated from a mass of condensed chromosomes (e). Bars: (a, 
b, c, and d)  10/~m; (e) 5 tzm. 
lmmunodepletion of Topo H from Extracts 
We wished to ask whether topo II plays an essential role in 
chromosome assembly and condensation in this assay. The 
most direct approach to address this question is either to de- 
plete topo II molecules from extracts or to block topo II ac- 
tivity by the addition of anti-topo II antibodies. For this pur- 
pose,  we cloned the Xenous topo II cDNAs and prepared 
specific anti-topo II antisera against bacterially expressed 
recombinant proteins (see Materials and Methods).  In the 
course of this study, we found that Xenopus  has two isotypes 
of topo II, cr  and/3,  as recently found in mammalian cells 
(Drake et  al.,  1989;  Chung  et  al.,  1989).  Northern  and 
Western blot analyses using isotype-specific probes revealed 
that only the c~ type of topo II is expressed in Xenopus eggs 
although the/3 type was predominantly detected in Xenopus 
liver nuclei (our own unpublished results).  Consistent with 
this result, when topo II o~ was depleted from egg extracts, 
no residual topo II activity was detected (see below). Taken 
together, we concluded that the expression of topo II/~ is ex- 
tremely low (<1% of o~) or absent in Xenopus eggs. On an 
immunoblot against Xenopus egg extracts, anti-topo II o~ rec- 
ognized a single band of 180 kD (Fig. 2 a), that corresponded 
well to that of Xenopus topo II biochemically characterized 
in oocytes and eggs (Benedetti et al., 1983; Luke and Bogen- 
hagen, 1989). Sperm chromatin was found to lack detectable 
levels of both isotypes of endogenous topo II as judged by 
Figure 2.  Immunodepletion  of topo II. (a) Immunodepletion  of 
topo 1I polypeptides  from extracts. A mitotic extract was treated 
with an anti-topo II antiserum or with a preimmune serum to pre- 
pare topo II--depleted and  mock-depleted  extracts,  respectively. 
Equal volumes of these extracts and an untreated extract were sub- 
jected to 7.5 % SDS-PAGE, blotted on a nitrocellulose paper, and 
probed with the anti-topo II antibody. (b) Immunodepletion of topo 
II  activity.  Kinetoplast  DNA  was  incubated  with  the  mock- 
depleted,  topo H-depleted,  and untreated extracts at 23~  After 
5-, 15-, and 60-min incubations, aliquots were taken and the reac- 
tions were terminated.  The DNA was deproteinized and analyzed 
on a 0.8% agarose gel.  In mock-depleted and untreated extracts, 
catenated DNA (catenated)  was rapidly decatenated to produce re- 
laxed minicircles and then converted into supercoiled ones as a re- 
sult of nucleosome  assembly (decatenated). (c) Nucleosome  as- 
sembly  in  the  topo H-depleted extract.  Nucleosome  assembly 
activity was measured as supercoiling of relaxed circular plasmid 
DNA.  Relaxed plasmid  DNA was added to the  mock-depleted, 
topo H-depleted,  and untreated extracts at a final concentration of 
10/zg/ml and incubated at 230C. After 0, 1/2, 1, and 3 h, aliquots 
were taken and the reactions were terminated.  The DNA was ana- 
lyzed as in b. L fully supercoiled DNA; L, relaxed circular DNA; 
II, nicked circular  DNA. 
immunoblotting and immunofluorescent staining  (data not 
shown).  In this paper we investigated the role of topo II o~ 
that is recruited from egg extracts to sperm chromatin. For 
simplicity we use the word '~opo IT' to refer to topo II c~ 
throughout the text unless otherwise indicated. 
We used the anti-topo II antisera to deplete topo II poly- 
peptides from egg extracts. By treating a mitotic extract with 
protein A-Sepharose beads that had been preloaded with an 
anti-topo II antiserum,  >95 % of topo II polypeptides were 
depleted from the extract as judged by immunoblotting (Fig. 
2  a).  As a  negative control, a preimmune serum collected 
from the same rabbit was used to prepare a mock-depleted 
extract. Topo II activity in the extracts was assayed for the 
ability  to  decatenate  kinetoplast  DNA  (Fig.  2  b).  In un- 
treated and mock-depleted extracts,  kinetoplast DNA was 
rapidly decatenated and converted into minicircles. In con- 
trast, in topo H-depleted extracts, no deeatenation activity 
was detected even after longer incubation.  We also found 
that topo II depletion has no effect on the efficiency of nu- 
cleosome assembly on a closed circular plasmid DNA (Fig. 
2 c). This is consistent with the previous reports that the tor- 
sionai stress induced on a circular plasmid DNA during nu- 
cleosome assembly in vitro is mostly removed by topoisom- 
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condensation.  Highly compact  sperm  chromatin (a)  was  mixed 
with a topo H--depleted  mitotic extract (b, d, and f), and the same 
extract complemented with highly purified Drosophila topo II at a 
final concentration of 1 t~g/ml (c, e, and g). This concentration of 
topo II was comparable to the physiological  level (see Materials and 
Methods). After 30-min (b and c), 1-h (d and e), and 2-h (f and 
g) incubations, chromatin structures were fixed, and stained with 
Hoechst 33258. Bar, 10 #m. 
erase I (topo I) rather than topo II (Almouzni and M~chali, 
1988). 
Topo H Is Required  for Mitotic Chromosome Assembly 
and Condensation 
The requirement for topo II in chromosome assembly and 
condensation was examined using the topo II-depleted mi- 
totic extracts.  In  the  absence of topo II,  highly compact 
sperm chromatin (Fig.  3 a) rapidly swelled but the subse- 
quent structural changes were completely blocked (Fig. 3, b, 
d, and  f). The swollen chromatin was uniformly stained with 
Hoechst, and showed no indication of local condensation or 
formation of thin chromatin fibers even after longer incuba- 
tion (at least 5 h).  We obtained identical results using ex- 
tracts depleted with another anti-topo 1I antiserum collected 
from a different rabbit or with afffinity-purified  anti-topo II 
IgG (see Materials and Methods). In mock-depleted extracts 
prepared  using  the  preimmune  serum,  sperm  chromatin 
Figure 4. Localization of topo II on condensation intermediates. 
Sperm chromatin was incubated with topo H-depleted (a and b) and 
mock-depleted mitotic extracts (c-h). After 15 min (c and d), 1 h 
(e and  f), and 2 h (a, b, g, and h), chromatin structures were fixed, 
and stained with Hoechst 33258 (a, c, e, and g) and afffinity-purified 
anti-topo II (b, d, f, and h). Bar, 10/~m. 
showed the identical structural changes to those observed in 
untreated extracts (data not shown). 
Another control for the specificity of depletion is to add 
back  purified topo  II  molecules.  The  addition  of highly 
purified Drosophila topo II into the topo II-depleted extracts 
at a physiological concentration (see Materials and Methods) 
restored the condensation activity (Fig. 3, c, e, and g). The 
time course of structural changes in the complemented ex- 
tract was  very similar to those observed in untreated ex- 
tracts.  After a 2-h incubation highly condensed individual 
chromosomes  were  formed.  Final  condensation  state  of 
these  chromosomes was  indistinguishable  from that  pro- 
duced in control extracts  (Fig.  1 d  and Fig.  3  g).  These 
results show that topo II is not required for the swelling step 
but is essential for the subsequent stages of chromosome as- 
sembly and condensation. 
Localization  of Topo H and MPM-2 Antigens on 
Mitotic Chromosomes 
We next investigated the localization of topo II molecules 
that are recruited from extracts onto chromatin structures by 
immunofluorescence. In topo II-depleted mitotic extracts, 
anti-topo 1I did not stain decondensed snake-shaped chroma- 
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condensed chromosomes. Sperm chromatin was  incubated with 
mock-depleted mitotic extracts for 2.5 h. Assembled chromosomes 
were fixed, and stained with Hoechst 33258 (a and c), affinity-puff- 
fled anti-topo II (b), and a mAb MPM-2 (d). Bar, 10 #m. 
tin structures as expected (Fig. 4 b). In contrast, chromatin 
structures  incubated  with  mock-depleted  extracts  were 
strongly stained  with anti-topo H.  Topo II molecules ap- 
peared on the chromatin from early stages of condensation 
(Fig.  4  d),  and  were uniformly distributed on the entire 
length of entangled thin chromatin fibers (Fig. 4 f) and of 
highly condensed chromosomes (Fig. 4 h). The staining pat- 
terns of these structures with anti-topo II were very similar 
to those with a DNA binding dye Hoechst (Fig. 4, c, e, and 
g). In fully resolved chromosomes, topo II was distributed 
throughout the whole structures and was not restricted to the 
chromosomal axis (Fig. 5 b). Exogenously added Drosoph- 
ila topo II in complementation experiments was also found 
to show similar distribution (data not shown). 
We have previously shown that a  mAb  MPM-2,  which 
recognizes  a  class  of  mitosis-specific  phosphoproteins 
(Davis et al., 1983), stains both a "condensation core" of mi- 
totic chromosome-like structures assembled around naked 
DNA and a  central axis of mitotic chromosomes isolated 
from CHO cells (Hirano and Mitchison,  1991). The strong 
correlation between the assembly of  this substructure and the 
condensed  state  of the  chromosomes  suggested  that  the 
MPM-2 antigens may play an essential role in mitotic chro- 
mosome assembly and  condensation.  Consistent with the 
previous observation,  we found that  MPM-2  antigens are 
concentrated on axial region of  mitotic chromosomes assem- 
bled from sperm chromatin in vitro (Fig. 5 d). The staining 
pattern was clearly different from the distribution of topo II 
(Fig.  5 b). 
Topo H Activity Is Not Required for Structural 
Maintenance of  Mitotic Chromosomes 
We next asked if topo I! is involved in the structural main- 
tenance of mitotic chromosomes assembled in this system. 
It has been proposed that topo II plays a "loop-fastener" role 
in the organization of the chromatin loop domains (Gasser 
Figure 6. Topo II activity is not required for structural maintenance 
of  mitotic chromosomes. Several treatments were performed before 
(a, c, and e) or after (b, d, and f) chromosome assembly. (a, c, 
and e); sperm chromatin was incubated with mitotic extracts con- 
taining control rabbit IgG (10 #g/nil; a), anti-topo II IgG (10/~g/ml; 
c), and VM-26 (10 ~,M; e). After a 2-h incubation, chromosomes 
were fixed and stained with Hoechst 33258. We obtained similar 
results when the extracts were pretreated 30 rain before the addition 
of sperm chromatin. (b, d, and f); mitotic chromosomes were as- 
sembled by incubating sperm chromatin with an untreated mitotic 
extract for 2 h. The reaction mixture was divided into three ali- 
quots, and control rabbit IgG (10 ~g/ml; b), anti-topo II IgG (10 
t~g/ml; d), and VM-26 (50 #M; f) were added. After another l-h 
incubation, chromosomes were fixed and stained as above. Bar, 
10 ~m. 
and Laemmli, 1987; Adachi et al., 1991). If topo II activity 
is continuously required to organize the chromatin loops, the 
loss of topo II activity may induce global effects on the mor- 
phology of mitotic chromosomes. To test this possibility, we 
added afffinity-purified  anti-topo H  IgG into reaction mix- 
tures.  A  concentration of affinity-purified anti-topo H IgG 
(10/zg/ml)  efficiently blocked chromosome assembly and 
condensation when added before assembly (Fig. 6 c). How- 
ever, once condensation was completed, the same concentra- 
tion of the antibody did not induce any detectable changes 
on the morphology of condensed chromosomes (Fig. 6 d). 
To rule out a possibility that the antibody may not be accessi- 
ble to all topo II molecules associated with chromosomes, 
a topo II inhibitor was also tested. The addition of a topo II 
inhibitor VM-26 has similar effects to those observed by the 
addition of anti-topo II IgG: as low as 10/zM of VM-26 is 
sufficient to block local condensation that follows chromatin 
swelling (Fig. 6 e), whereas even high concentration of the 
same drug (50-100 #M) induced no remarkable changes on 
the  structure  of precondensed  chromosomes  (Fig.  6 f). 
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mild conditions. (A) Salt extraction. Mitotic chromosomes were as- 
sembled from sperm chromatin in vitro, and then mixed with an 
equal vol of EB containing increasing concentrations of NaC1. The 
extra concentrations of NaCI were 0 mM (a-d), 50 mM (e-h) and 
100 mM (i-l). After incubation at 23"C for 10 rain, chromosomes 
were fixed and stained with Hoochst 33258 (a, c, e, g, i, and k), 
affinity-purified anti-topo II (b,f, and j) and MPM-2 (d, h, and l). 
Bar, 10/~m. (B) Dextran sulfate extraction. Mitotic chromosomes 
were assembled from sperm chromatin in vitro, and then dextran 
sulfate was added to a final concentration of 100 tzg/ml. Chromo- 
somes were fixed and stained with Hoechst 33258 (a and c), affinity- 
purified anti-topo  11 (b), and MPM-2  (d).  Bar, 10 #m. 
These results  suggest that  continuous  catalytic activity of 
topo 11 may not be required for the structural maintenance 
of mitotic chromosomes once their  condensation  is  com- 
pleted. 
Topo II Is Dissociated from Mitotic Chromosomes 
under Mild Conditions 
To test further a possible scaffolding role of topo 1I, we next 
attempted to extract mitotic chromosomes assembled in our 
system. Conventional procedures for scaffold preparation in- 
volve a number of experimental steps including chromosome 
isolation from drug-arrested mitotic cells, scaffold stabiliza- 
tion, and historic extraction. Any of these steps could poten- 
tially induce  nonphysiological effects on the  chromosome 
morphology. In contrast, in our in vitro assembly system, it 
is possible to manipulate chromosomes directly in the as- 
sembly mixtures without any isolation or stabilization steps. 
Surprisingly, we found that topo II can be extracted from 
mitotic chromosomes under mild conditions where the mor- 
phology  of the  chromosomes  is  well  preserved.  Mitotic 
chromosomes were assembled in EB (80 mM B-glycerophos- 
phate,  pH 7.3,  15  mM MgC12, 20 mM EGTA and  1 mM 
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condition and then mixed with the same buffer containing in- 
creasing concentrations of NaC1. When extra concentration 
of NaC1 in an assembly mixture was raised to 50 mM, the 
rod-shaped chromosomes expanded slightly as judged by 
Hoechst staining (Fig. 7 A, e and g). At 100 mM, the chro- 
matin expanded further to form a small halo around a central 
axis of  each chromosome (Fig. 7 A, i and k). These structural 
changes were highly uniform and reproducible. Under these 
relatively mild conditions, tope II molecules were dissoci- 
ated  from the  mitotic  chromosomes.  By  immunofluores- 
cence, topo II staining was greatly reduced at 50 mM NaCI 
and residual, faint signal was observed restricted on a central 
axis of the expanded chromosomes (Fig. 7 A, f). No detect- 
able signal was observed at 100 mM NaCl, indicating that 
topo II was completely extracted at this salt concentration 
(Fig. 7 A, j). In contrast to tope II, MPM-2 antigens were 
relatively resistant to the same treatments. Fluorescent in- 
tensity on the axis was slightly reduced but the discrete stain- 
ing pattern did not change (Fig. 7 A, h and l). Interestingly, 
we noted that MPM-2 also stained tips at both ends of chro- 
mosomes  and  a  patch  located on the  central axis  in  the 
expanded chromosomes.  Presumably these correspond to 
telomeres and the kinetochores, respectively. While these 
structures  are  present  in  unextracted chromosomes,  they 
were clearly visualized on chromosomes extracted at extra 
50 mM NaC1 due to a slight reduction of total staining inten- 
sity on the central axis (Fig. 7 A, h). 
A different extraction procedure also efficiently extracted 
topo II molecules from mitotic chromosomes assembled in 
vitro.  Dextran sulfate,  a  negatively charged polymer, has 
been used to extract chromosomal proteins by competition 
with DNA in a low ionic strength condition (Lewis and Laem- 
mli,  1982). When dextran sulfate was added at a final con- 
centration of 100 ~g/ml into an assembly mixture after con- 
densation was completed, the length of the chromosomes 
increased substantially (at least twofold) and the chromatin 
swelled to form a large halo around a central axis.  Under 
these conditions the chromosomes tended to aggregate, but 
individual chromosomes were clearly visualized (Fig. 7 B, 
a and c). When these structures were stained with anti-tope 
II, no immunofluorescent signal was detected (Fig. 7 B, b). 
In contrast, MPM-2 strongly stained the axis but not the halo 
(Fig.  7 B, d). 
Immunoblot analysis confirmed that topo II polypeptides 
were dissociated from mitotic chromosomes under these ex- 
traction  conditions.  Control  and  extracted  chromosomes 
were partially purified by centrifugation, and the amounts of 
topo II coprecipitated with chromosomes were analyzed by 
immunoblotting (Fig.  8).  Consistent with immunofluores- 
cent data, no detectable level of topo II (<29~  of the unex- 
tracted control) was found in the pellet when treated with ex- 
tra  0.1  M  NaC1  or  100  /~g/ml  dextran  sulfate,  although 
chromosomal  DNA  was  quantitatively  recovered  under 
these conditions (data not shown). 
Since chromosome organization and axial structures are 
maintained after topo II extraction, we conclude that topo 
II does not play a  scaffolding role in the structural main- 
tenance of mitotic chromosomes assembled in this system. 
Changes of Topo H Distribution under 
Artifactual Conditions 
Although topo II molecules were completely extracted from 
Figure 8. Immunoblot analysis of topo II extraction. Sperm chro- 
matin was incubated with mitotic extracts in the standard condition 
(lanes 3-10) for 2 h. As negative controls, no mitotic extract (lane 
1) or no sperm chromatin (lane 2) was added. Assembled chromo- 
somes were treated with NaCI (lanes 3-7) or dextran sulfate (lanes 
8-10) at final concentrations as indicated and then partially purified 
by centrifugation. Topo  II molecules coprecipitated with the chro- 
mosomes were analyzed by immunoblotting. A dilution series of 
the untreated chromosome sample (equivalent  to lane 3) was loaded 
in the same gel as standards (standard;  lanes 11-16). 
mitotic chromosomes with extra 0.1 M NaCI (Fig. 7 A, j), 
there was a  tendency that,  in a milder condition, residual 
topo II was found on the chromosomal axis (Fig. 7 A, f). 
This observation suggested that topo II  may have higher 
affinity for the axial region of chromatin compared with pe- 
ripheral region. To test this possibility, we screened several 
conditions that might affect the distribution of topo II in mi- 
totic chromosomes (Table I). 
When EtBr (ethidium bromide) was added at a final con- 
centration of 50 #g/ml,  the rod-shaped chromosomes ex- 
panded slightly (Fig. 9 c) and topo II was found concentrated 
on an axial region (Fig. 9 d). At higher concentration of  EtBr 
(100 ~g/mi), the central axis was surrounded by a large halo 
of chromatin (Fig. 9 e). In these chromosomes, total fluores- 
cent signal with anti-topo II was greatly reduced and the re- 
sidual topo II was restricted to the axis (Fig. 9 f). Since it 
is  known  that  EtBr  intercalates  into  DNA  and  unwinds 
double-stranded DNA, this result suggests that changes of 
DNA topology may induce a gross rearrangement of topo II 
distribution in mitotic chromosomes. 
Copper ion is known to specifically stabilize the scaffold 
structure of isolated  chromosomes (Lewis  and  Laemmli, 
1982). We found that addition of CuSO4 at a final concen- 
tration of 0.5 mM induced a slight expansion of rod-shaped 
chromosomes (Fig. 9 g). In these expanded chromosomes, 
tope II was not uniformly distributed but was found concen- 
trated on an axial region (Fig.  9  h).  The effect was Cu  e+ 
specific: any divalent cation other than Cu  e+ we have tested 
did not induce either the expansion of chromosomes or the 
change of topo II distribution (Table I). We attempted chro- 
mosome  extraction  with  extra  0.1  M  NaCI  after  these 
pretreatments, but failed to find a condition that causes tight 
association of tope II with the chromosomes (Table I). 
Discussion 
Mitotic Chromosome Assembly  from 
Sperm Chromatin In Vitro 
Upon fertilization, in vivo, sperm chromatin is induced to 
form the male pronucleus, and then is converted into mitotic 
chromosomes  after  the  fusion  with  the  female  nucleus. 
Therefore, the "mitotic" pathway in which sperm chromatin 
is directly induced to produce condensed chromosomes is 
less physiological than the "interphase-to-mitodC pathway in 
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No extraction 
Pretreatments  Chromosome  morphology  Topo II staining 
0.1  M NaCl extraction 
Chromosome morphology  Topo II staining 
No treatment  Rod  + +  Halo  - 
50 #g/ml EtBr  Expanded  + +  (axis)  Large halo  - 
I00/zg/ml EtBr  Halo  +  (axis)  Large halo  +  (axis) 
0.5 mM CuSO4  Expanded  + +  (axis)  Large halo  - 
0.5 mM MgSO4  Rod  + +  Halo  - 
0.5 mM ZnSO4  Rod  + +  Halo  - 
0.5 mM MnSO4  Rod  + +  Halo  - 
0.5 mM CoC12  Rod  + +  Halo  - 
0.5 mM CaC12  Rod  + +  Halo  - 
0.5 mM CuSO4 (37~  Expanded  + +  (axis)  Large halo  +  (axis) 
0.5 mM CaC12 (37~  Rod  + +  Halo  - 
37~  Rod  + +  Halo  - 
20 mM EDTA  Rod  +  Halo  +  (axis) 
Mitotic chromosomes were assembled from sperm chromatin in the standard condition at 23~  for 2 h. Pretreatments were performed at 23 or 370C for 10 min. 
The reaction mixtures were divided into two aliquots and then mixed with an equal vol of EB (no extraction) or EB containing 0.2 M NaCI (0. I M NaCl extraction). 
After incubation at 230C for 10 min, chromosome morphology and topo II localization was examined by immunofluorescence. The intensity of topo II staining 
was based on the examination by eye and is not quantitative.  Chromosomes were uniformly  stained with anti-topo II unless otherwise indicated. 
Figure 9. Artifactual  changes of  topo II distribution  in mitotic chro- 
mosomes. Mitotic chromosomes were assembled from sperm chro- 
matin in vitro in the standard condition and then EtBr (a and b, 0 
/zg/ml; c and d, 50/zg/ml; e and f,  100/xg/ml) or CuSO4 (g and 
h, 0.5  mM) was added.  After  10 min incubation,  chromosomes 
were fixed and stained  with Hoechst 33258 (a,  c, e,  and g) and 
afffinity-purified anti-topo II IgG (b, d, f, and h).  Bar,  l0/zm. 
which mitotic chromosomes are produced from interphase 
nuclei containing replicated  DNA.  However, even the for- 
mer pathway examined in this study produces mitotic chro- 
mosomes with a good morphology and a final condensation 
state similar to that observed in vivo. Thus results obtained 
with this assay for studying the mechanism of chromosome 
condensation are relevant to the physiological mechanism. 
We have investigated in detail the structural rearrangements 
of sperm chromatin observed in mitotic extracts and charac- 
terized the four intermediate  stages as follows: (a) swelling 
of highly compact sperm chromatin; (b) local condensation; 
(c) formation of entangled thin fibers; and (d) resolution of 
highly condensed chromosomes. The thin chromatin fibers 
observed in stage c  have a  diameter of ~0.2-0.4  #m, pre- 
sumably corresponding to prophase chromosomes. The final 
condensed products observed in stage d  with a  diameter of 
~0.8/~m  may represent  fully condensed metaphase  chro- 
matids.  Our  impression  from fluorescence morphology is 
that the last step of condensation appears to involve coiling 
of the thin fibers (Fig.  1, d and e). However, more extensive 
morphological studies will be needed to clarify the structural 
details  of the condensation processes in this  system, 
Role of Topo H in Mitotic Chromosome Assembly and 
Organization In Vitro 
It is  well  known that  sperm  chromatin mostly consists  of 
sperm-specific chromatin proteins that are replaced by em- 
bryonic ones upon fertilization (reviewed by Poccia,  1989). 
It is therefore possible to investigate specific function of non- 
sperm chromatin components recruited from extracts under 
a physiological condition in our system. Since we have found 
that Xenopus sperm chromatin lacks detectable amounts of 
both isotypes of endogenous topo II (o~ and fl),  the u  type 
present in the extracts is the only source of topo II molecules 
to be considered for mitotic chromosome assembly and con- 
densation in vitro.  Our depletion and complementation ex- 
periments have clearly demonstrated that topo II (t~) is re- 
quired  for  chromosome  assembly  and  condensation  that 
follows swelling of sperm chromatin. This is in good agree- 
ment with Adachi et al.  (1991),  who used chicken erythro- 
cyte nuclei as a substrate with a low level of  endogenous topo 
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significant difference. Adachi et al. (1991) observed that in 
topo II-depleted extracts erythrocyte nuclei are converted 
into  partially  resolved,  uncondensed  chromatids  called 
"precondensation chromosomes" (pcXs),  whereas  we  ob- 
served no indication of resolution in the swollen sperm chro- 
matin in the absence of topo II. At the moment we do not 
know if the discrepancy is due to either the different conden- 
sation mechanisms or the different protein composition in 
the nuclei used for these two studies. 
It was not clear if topo II has a structural role in the main- 
tenance of mitotic chromosomes from previous studies in 
vitro  (Newport  and  Spann,  1987; Wood  and  Earnshaw, 
1990; Adachi et al., 1991). Adachi et al. (1991) argued in fa- 
vor of structural involvement of  topo II based on their dosage 
experiment: a certain dose of topo II in an extract induced 
partial but not complete condensation even after longer incu- 
bation, leading to the suggestion that the reaction is not ex- 
clusively catalytic. Since we have found that topo II is indeed 
associated with mitotic chromosomes assembled in vitro, 
one would expect our condensation system to reflect a struc- 
tural requirement for topo II function. In principle, two types 
of structural requirement could be considered. Topo II may 
be required as part of an axial, scaffold structure, or alterna- 
tively it could play a more diffuse structural role in chromo- 
some condensation. We presented two lines of evidence to 
suggest that topo II does not play a scaffolding role in mi- 
totic chromosome organization in our system. First, once 
condensation is completed, inhibition of topo II activity has 
little effect on the morphology of condensed chromosomes. 
Second and more convincing evidence is that topo II mole- 
cules can be dissociated from mitotic chromosomes under 
mild conditions where the shape of chromosomes is well 
preserved and the condensation state is little altered, particu- 
larly along the length of the chromosomes. We obtained 
identical results using two different extraction procedures, 
either by increasing ionic strength or by adding a polyanion 
to assembly mixtures. All detectable topo II molecules were 
extracted in both conditions, whereas other chromosomal 
antigens  recognized  with  a  mAb  MPM-2  remained  as- 
sociated with a central axis of chromosomes. Although we 
cannot rule out the possibility that topo II also has a low level 
of MPM-2 epitope, the differential extraction pattern sug- 
gests that the predominant chromosomal MPM-2 antigens 
are distinct from topo II. 
Since one could argue that our analyses may not be sensi- 
tive enough to detect small, but significant amounts of topo 
lI remaining in the extracted chromosomes, it is important 
to estimate the stoichiometry of topo II in mitotic chromo- 
somes. Based ontheDNA concentration of sperm chromatin 
added into extracts and the amount of topo II coprecipitated 
with condensed chromosomes (as judged by quantitative im- 
munoblotting), we estimate that topo II/DNA ratio is 5-10 
kb per topo II dimer in the unextracted chromosomes. When 
extracted with extra 0.1 M NaC1, the amount of residual topo 
II was <2% of the unextracted control, thus giving a ratio 
of not less than 250-500 kb per topo II dimer. This value 
is far beyond the topo II level in isolated chromosomes (•50 
kb per topo 1I dimer; Gasser et al.,  1986). 
Thus our data argue that while a chromosome scaffold  may 
exist, topo II is not required for its structural maintenance 
in this system at least once condensation is completed. How- 
ever, we cannot rule out the possibility that topo II acts as 
a "loop fastener" in early stages of chromosome assembly. 
Our data do not address whether topo II plays a more diffuse 
structural role in maintaining condensation. When topo II 
was extracted, slight swelling always occurred, but we can- 
not tell whether this was due to extraction of topo II or some 
other chromosomal proteins. 
Factors Affecting Topo  H Localization in Mitotic 
Chromosomes Assembled In Vitro 
Our immunofluorescence data showed uniform distribution 
of topo II on condensed chromosomes, but in particular ex- 
traction conditions residual topo II was found concentrated 
on a central axis (e.g., Figs. 7 A, f  and 9 f). Topo II may 
in fact have high affinity for the axial region of chromatin 
compared with peripheral regions. EtBr treatments of con- 
densed chromosomes suggested that changes of DNA topol- 
ogy potentially induce partial release or redistribution of 
topo II. A recent finding that topo II has high affinity for su- 
percoiled DNA by preferentially interacting with DNA cross- 
overs (Zechiedrich and Osheroff,  1990)  may account for 
our observation. Since torsional stress of DNA introduced 
by intercalation of EtBr is removed by topo I present in the 
assembly mixtures, topologically relaxed chromatin loops 
become expanded and thus lose their affinity for topo II. In 
contrast, the axial chromatin may be relatively resistant to 
the treatment and maintains a high density of DNA cross- 
overs that provide high affinity binding sites for topo II. An- 
other factor that potentially affects topo II localization is 
copper ion, which has been used for the stabilization of the 
chromosome scaffold structure (Lewis and Laemmli, 1982). 
When mitotic chromosomes are  incubated with 0.5  mM 
CuSO,, topo II was found concentrated on an axial region 
although the mechanism of this effect is not clear. We also 
found that several pretreatments of chromosomes affect the 
efficiency of topo II extraction with extra 0.1 M NaCI (Table 
I), but even in these conditions the level of residual topo II 
was <5 % of an unextracted control as judged by quantitative 
immunoblotting. It should be emphasized that all these treat- 
ments affecting the behavior of topo II, when applied before 
assembly, prevent chromosome condensation in our system 
(data not shown), and thus seem to be nonphysiological. 
In Vivo Chromosomes vs In Vitro Chromosomes 
Previous morphological and biochemical analyses of mitotic 
chromosomes isolated from somatic tissue culture cells sug- 
gested that topo II is an integral scaffold component required 
for the maintenance of mitotic chromosome structure (Earn- 
shaw et al., 1985; Gasser et al., 1986). Inconsistent with this 
notion, our results obtained from an in vitro assembly sys- 
tem have shown that topo II does not play a scaffolding role 
at least once condensation is completed. While it is not easy 
to reconcile the discrepancy of these studies at present,  it 
will be important to clarify the potential differences between 
the two systems and to evaluate their characteristics care- 
fully. One important question is the extent to which chromo- 
some assembly achieved in Xenopus egg extracts  strictly 
mimics that observed in somatic cells. It has been suggested 
that some chromosomal events in the early embryonic cell 
cycle may be significantly  different from those in the somatic 
one.  These include mechanisms of nucleosome assembly 
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(reviewed by Laskey and Leno,  1990).  Extensive morpho- 
logical and biochemical analyses will be required to answer 
this question and our results will be most relevant  to em- 
bryonic chromosome structures.  Despite this potential prob- 
lem, dissection of mitotic chromosomes assembled in vitro 
has a major advantage  over the previous studies using chro- 
mosomes isolated from somatic cells.  As demonstrated in 
this paper, we can manipulate "native" chromosomes in their 
assembly  condition without any  isolation and  stabilization 
steps. In principle, any procedures for chromosome isolation 
may result in structural changes. Even colcemid treatment of 
mitotic cells can cause morphological changes of chromo- 
somes  (reviewed  by  Rieder  and  Palazzo,  1992)  and  a 
relocalization of some chromosomal antigens (Earnshaw and 
Cooke,  1991;  Compton  et  al.,  1991;  1992).  It  should  be 
noted that in previous studies topo II was localized on a cen- 
tral axis only when mitotic chromosomes were experimen- 
tally swollen or expanded (Earnshaw  and Heck, 1985; Gas- 
ser et al.,  1986).  These studies, although they paid careful 
attention  to  maintaining  a  native  state  of chromosomes, 
should be re-evaluated  because our data  implies that even 
mild treatments potentially induce partial release or relocali- 
zation of topo II molecules in mitotic chromosomes. 
In conclusion, our in vitro system provides a complemen- 
tary approach to the conventional studies dissecting mitotic 
chromosomes  isolated  from  somatic  cells.  Comparative 
evaluation  of the results  obtained from the two systems will 
contribute to our comprehensive understanding  of mitotic 
chromosome structure  and organization. 
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